COMP <GO>
GFF vs TMO // RETURN ON INVESTED CAPITAL (ROIC)
Griffon Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GFF 4
— TMO 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: GFF
LAST: $102.92 (+3.05%) • MKT CAP: $4.66B
roic
12.00%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
roic
9.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GFF VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GFF | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 12.00% | 9.30% | +2.70 | GFF | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.6x | 30.4x | -6.80 | GFF | /valuation <GO> |
| Free Cash Flow Yield | — | 2.40% | — | TIE | /fcf-yield <GO> |
| Operating Margin | 8.20% | 17.40% | -9.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.00% | 15.10% | -13.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -3.90% | 3.90% | -7.80 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.85% | 0.24% | +0.61 | GFF | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.31 | 4.50 | -1.19 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.1 | 62.9 | +1.16 | GFF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 84.8x | 36.3x | +48.50 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.66B | $262.22B | -$257.56B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GFF REV | TMO REV | GFF GROSS % | TMO GROSS % | GFF FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.52B | $44.56B | 42.0% | — | — | $6.29B |
| FY 2024 | $2.62B | $42.88B | 38.9% | — | — | $7.27B |
| FY 2023 | $2.69B | $42.86B | — | — | — | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GFF // BETA —
TMO // BETA 0.94